US20180221396A1 | Compositions and methods comprising a psilocybin derivative
Priority Date: 2017-02-09 | Status: Pending in US
General Subject Matter: Purified psilocybin derivatives, some together with cannabinoids and terpenes, for treatment of psychological disorders